Inhibition of novel β coronavirus replication by a combination of interferon-α2b and ribavirin

The identification of a novel β coronavirus, nCoV, as the causative agent of severe respiratory illness in humans originating in Saudi Arabia, Qatar and Jordan has raised concerns about the possibility of a coronavirus pandemic similar to that of SARS-CoV. As a definitive treatment regimen has never...

Descripción completa

Detalles Bibliográficos
Autores principales: Falzarano, Darryl, de Wit, Emmie, Martellaro, Cynthia, Callison, Julie, Munster, Vincent J., Feldmann, Heinz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2013
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3629412/
https://www.ncbi.nlm.nih.gov/pubmed/23594967
http://dx.doi.org/10.1038/srep01686

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3629412/
https://www.ncbi.nlm.nih.gov/pubmed/23594967
http://dx.doi.org/10.1038/srep01686

Ejemplares similares